Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Synthesis and modification of uniform PEG-neridronate-modified magnetic nanoparticles determines prolonged blood circulation and biodistribution in a mouse preclinical model

V. Patsula, D. Horák, J. Kučka, H. Macková, V. Lobaz, P. Francová, V. Herynek, T. Heizer, P. Páral, L. Šefc,

. 2019 ; 9 (1) : 10765. [pub] 20190724

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028869

Magnetite (Fe3O4) nanoparticles with uniform sizes of 10, 20, and 31 nm were prepared by thermal decomposition of Fe(III) oleate or mandelate in a high-boiling point solvent (>320 °C). To render the particles with hydrophilic and antifouling properties, their surface was coated with a PEG-containing bisphosphonate anchoring group. The PEGylated particles were characterized by a range of physicochemical methods, including dynamic light scattering, transmission electron microscopy, thermogravimetric analysis, Fourier transform infrared spectroscopy, and magnetization measurements. As the particle size increased from 10 to 31 nm, the amount of PEG coating decreased from 28.5 to 9 wt.%. The PEG formed a dense brush-like shell on the particle surface, which prevented particles from aggregating in water and PBS (pH 7.4) and maximized the circulation time in vivo. Magnetic resonance relaxometry confirmed that the PEG-modified Fe3O4 nanoparticles had high relaxivity, which increased with increasing particle size. In the in vivo experiments in a mouse model, the particles provided visible contrast enhancement in the magnetic resonance images. Almost 70% of administrated 20-nm magnetic nanoparticles still circulated in the blood stream after four hours; however, their retention in the tumor was rather low, which was likely due to the antifouling properties of PEG.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028869
003      
CZ-PrNML
005      
20210114155239.0
007      
ta
008      
210105s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-019-47262-w $2 doi
035    __
$a (PubMed)31341232
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Patsula, Vitalii $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic.
245    10
$a Synthesis and modification of uniform PEG-neridronate-modified magnetic nanoparticles determines prolonged blood circulation and biodistribution in a mouse preclinical model / $c V. Patsula, D. Horák, J. Kučka, H. Macková, V. Lobaz, P. Francová, V. Herynek, T. Heizer, P. Páral, L. Šefc,
520    9_
$a Magnetite (Fe3O4) nanoparticles with uniform sizes of 10, 20, and 31 nm were prepared by thermal decomposition of Fe(III) oleate or mandelate in a high-boiling point solvent (>320 °C). To render the particles with hydrophilic and antifouling properties, their surface was coated with a PEG-containing bisphosphonate anchoring group. The PEGylated particles were characterized by a range of physicochemical methods, including dynamic light scattering, transmission electron microscopy, thermogravimetric analysis, Fourier transform infrared spectroscopy, and magnetization measurements. As the particle size increased from 10 to 31 nm, the amount of PEG coating decreased from 28.5 to 9 wt.%. The PEG formed a dense brush-like shell on the particle surface, which prevented particles from aggregating in water and PBS (pH 7.4) and maximized the circulation time in vivo. Magnetic resonance relaxometry confirmed that the PEG-modified Fe3O4 nanoparticles had high relaxivity, which increased with increasing particle size. In the in vivo experiments in a mouse model, the particles provided visible contrast enhancement in the magnetic resonance images. Almost 70% of administrated 20-nm magnetic nanoparticles still circulated in the blood stream after four hours; however, their retention in the tumor was rather low, which was likely due to the antifouling properties of PEG.
650    _2
$a zvířata $7 D000818
650    _2
$a bisfosfonáty $x chemie $7 D004164
650    _2
$a železité sloučeniny $7 D005290
650    _2
$a magnetická rezonanční tomografie $7 D008279
650    _2
$a magnetické nanočástice $x chemie $x ultrastruktura $7 D058185
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a transmisní elektronová mikroskopie $7 D046529
650    _2
$a velikost částic $7 D010316
650    _2
$a polyethylenglykoly $x chemie $7 D011092
650    _2
$a tkáňová distribuce $7 D014018
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Horák, Daniel $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic. horak@imc.cas.cz.
700    1_
$a Kučka, Jan $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Macková, Hana $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Lobaz, Volodymyr $u Institute of Macromolecular Chemistry, Czech Academy of Sciences, Heyrovského nám. 2, 162 06, Prague 6, Czech Republic.
700    1_
$a Francová, Pavla $u Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic.
700    1_
$a Herynek, Vít $u Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic.
700    1_
$a Heizer, Tomáš $u Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic.
700    1_
$a Páral, Petr $u Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic.
700    1_
$a Šefc, Luděk $u Center of Advanced Preclinical Imaging, First Faculty of Medicine, Charles University, Salmovská 3, 120 00, Prague 2, Czech Republic.
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 9, č. 1 (2019), s. 10765
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31341232 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114155238 $b ABA008
999    __
$a ok $b bmc $g 1609204 $s 1120049
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 9 $c 1 $d 10765 $e 20190724 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...